Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tezepelumab significantly reduced asthma exacerbations for a broad population of patients with sever

worldpharmanewsSeptember 07, 2017

Tag: Tezepelumab , Asthma

PharmaSources Customer Service